CareDx 주식 주식분석 | 주식가격 | 뉴스 | CDNA | US14167L1035 | A118WG

날짜	CareDx 주식 가격
	21.84 undefined
	21.56 undefined
	21.17 undefined
	21.55 undefined
	24.15 undefined
	23.32 undefined
	23.34 undefined
	23.65 undefined
	23.88 undefined
	23.21 undefined
	22.90 undefined
	22.93 undefined
	22.64 undefined
	22.13 undefined
	22.98 undefined
	22.60 undefined
	22.89 undefined
	22.39 undefined
	22.85 undefined
	23.11 undefined
	23.14 undefined
	23.47 undefined

날짜	CareDx 매출	CareDx EBIT	CareDx 이익
2026e	421.46 백만 undefined	27.59 백만 undefined	40.12 백만 undefined
2025e	369.68 백만 undefined	-960,115.8 undefined	29.15 백만 undefined
2024e	335.28 백만 undefined	-5.76 백만 undefined	20.4 백만 undefined
2023	280.32 백만 undefined	-104.04 백만 undefined	-190.28 백만 undefined
2022	321.8 백만 undefined	-77.2 백만 undefined	-76.6 백만 undefined
2021	296.4 백만 undefined	-29.7 백만 undefined	-30.7 백만 undefined
2020	192.2 백만 undefined	-22.5 백만 undefined	-18.7 백만 undefined
2019	127.1 백만 undefined	-24.5 백만 undefined	-22 백만 undefined
2018	76.6 백만 undefined	-15.6 백만 undefined	-46.8 백만 undefined
2017	48.3 백만 undefined	-18.3 백만 undefined	-55.5 백만 undefined
2016	40.6 백만 undefined	-24.3 백만 undefined	-39.5 백만 undefined
2015	28.1 백만 undefined	-11.9 백만 undefined	-13.7 백만 undefined
2014	27.3 백만 undefined	1.3 백만 undefined	800,000 undefined
2013	22.1 백만 undefined	-900,000 undefined	-3.5 백만 undefined
2012	20.5 백만 undefined	-2.3 백만 undefined	-5.1 백만 undefined
2006	2.9 백만 undefined	-20.2 백만 undefined	-19.9 백만 undefined
2005	300,000 undefined	-16.3 백만 undefined	-16.6 백만 undefined
2004	0 undefined	-13 백만 undefined	-13 백만 undefined
2003	0 undefined	-7.5 백만 undefined	-7.5 백만 undefined
2002	0 undefined	-2.9 백만 undefined	-3.6 백만 undefined

	매출	EBIT	이익
2002	0 USD	-2.9 백만 USD	-3.6 백만 USD
2003	0 USD	-7.5 백만 USD	-7.5 백만 USD
2004	0 USD	-13 백만 USD	-13 백만 USD
2005	300,000 USD	-16.3 백만 USD	-16.6 백만 USD
2006	2.9 백만 USD	-20.2 백만 USD	-19.9 백만 USD
2012	20.5 백만 USD	-2.3 백만 USD	-5.1 백만 USD
2013	22.1 백만 USD	-900,000 USD	-3.5 백만 USD
2014	27.3 백만 USD	1.3 백만 USD	800,000 USD
2015	28.1 백만 USD	-11.9 백만 USD	-13.7 백만 USD
2016	40.6 백만 USD	-24.3 백만 USD	-39.5 백만 USD
2017	48.3 백만 USD	-18.3 백만 USD	-55.5 백만 USD
2018	76.6 백만 USD	-15.6 백만 USD	-46.8 백만 USD
2019	127.1 백만 USD	-24.5 백만 USD	-22 백만 USD
2020	192.2 백만 USD	-22.5 백만 USD	-18.7 백만 USD
2021	296.4 백만 USD	-29.7 백만 USD	-30.7 백만 USD
2022	321.8 백만 USD	-77.2 백만 USD	-76.6 백만 USD
2023	280.32 백만 USD	-104.04 백만 USD	-190.28 백만 USD
2024e	335.28 백만 USD	-5.76 백만 USD	20.4 백만 USD
2025e	369.68 백만 USD	-960,115.8 USD	29.15 백만 USD
2026e	421.46 백만 USD	27.59 백만 USD	40.12 백만 USD

2002	2003	2004	2005	2006	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
0	0	0	0	2	20	22	27	28	40	48	76	127	192	296	321	280	335	369	421
-	-	-	-	-	900.00	10.00	22.73	3.70	42.86	20.00	58.33	67.11	51.18	54.17	8.45	-12.77	19.64	10.15	14.09
-	-	-	-	8,900.00	60.00	59.09	66.67	60.71	47.50	56.25	56.58	63.78	67.19	67.23	65.11	63.57	53.13	48.24	42.28
0	0	0	-1	0	12	13	18	17	19	27	43	81	129	199	209	178	0	0	0
-3	-7	-13	-16	-19	-5	-3	0	-13	-39	-55	-46	-22	-18	-30	-76	-190	20	29	40
-	133.33	85.71	23.08	18.75	-73.68	-40.00	-	-	200.00	41.03	-16.36	-52.17	-18.18	66.67	153.33	150.00	-110.53	45.00	37.93
27.8	27.8	27.8	27.8	27.8	1	1	9.3	11.9	16.5	23.3	35.6	42.2	46.5	52.2	53.3	53.76	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2005	2006	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

24.8	15.9	5.8	5.1	36.4	29.9	17.3	16.9	64.6	38.2	224.7	348.5	293.1	235.42
0	0.4	1	2.3	2.7	2.4	2.8	3	9.8	24.1	34.6	59.8	66.3	51.06
0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.4	0.3	0.6	0.5	0.7	0.8	5.5	5.5	4.9	6	10	17.2	19.2	19.47
0.2	0.3	0.2	0.3	0.5	1.3	1.2	1.4	1.8	3.6	3.8	7.9	9.2	7.76
25.4	16.9	7.6	8.2	40.3	34.4	26.8	26.8	81.1	71.9	273.1	433.4	387.8	313.71
1.1	5.6	2.1	1.6	2	2.4	2.9	2.1	4.1	9.2	25.9	40	70.2	65.14
0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	6.7	6.7	33.1	33.1	33.3	45.5	44.4	50.2	43.1	45.7
0	0	0	0	12	12	13.8	12	12	23.9	23.9	37	37.5	40.34
0.3	0.5	0.2	0.1	0.2	0.2	0.2	9.6	0.2	1.3	1.3	6	4.4	1.94
1.4	6.1	2.3	1.7	20.9	21.3	50	56.8	49.6	79.9	95.5	133.2	155.2	153.11
26.8	23	9.9	9.9	61.2	55.7	76.8	83.6	130.7	151.8	368.6	566.6	543	466.83

68.4	68.4	135.2	135.2	0	0	0	0	0	0	0	0.1	0.1	0.05
0.6	1.1	9.4	9.5	200.7	202.6	235.7	264.2	412	438	632.3	853.7	898.8	946.51
-46.7	-66.5	-156.6	-160.2	-159.4	-173.1	-212.6	-268	-311.8	-333.8	-352.5	-383.2	-460.4	-678.27
0	0	0	0	0	0	-3.7	-2.3	-4.3	-5.2	-2.1	-4.7	-7.5	-6.96
0	0	0	0	0	0	0	0	0	0	0	0	0	0
22.3	3	-12	-15.5	41.3	29.5	19.4	-6.1	95.9	99	277.7	465.9	431	261.33
0.7	2	0.6	0.6	1.1	1.6	3.1	3.4	4.7	5.5	9.7	13.3	9.9	12.87
1.2	1.7	2.9	1.8	2.5	5.5	9.4	8.7	11.2	18.8	25.6	43.8	40.6	35.43
0.3	0.2	1.3	0.7	1.4	0.1	5.5	15	3.4	10.5	33.9	20.2	25.4	29.77
0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.2	4	1.5	4.5	6	2.9	22.8	15.7	0.2	0	0.1	0	0	0
2.4	7.9	6.3	7.6	11	10.1	40.8	42.8	19.5	34.8	69.3	77.3	75.9	78.07
0.1	6.2	13.4	11.4	5.5	12.9	1.1	18.3	0	0	0	0	0	0
0	0	0	0	0	0	6.1	4.9	3	2	1.3	0.4	0	0.14
2.1	6	2	6.3	3.3	3.1	9	23.3	12.3	15.9	20.3	23	36.1	127.29
2.2	12.2	15.4	17.7	8.8	16	16.2	46.5	15.3	17.9	21.6	23.4	36.1	127.43
4.6	20.1	21.7	25.3	19.8	26.1	57	89.3	34.8	52.7	90.9	100.7	112	205.5
26.9	23.1	9.7	9.8	61.1	55.6	76.4	83.2	130.7	151.7	368.6	566.6	543	466.83

2004	2005	2006	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
-13	-16	-19	-5	-3	0	-13	-39	-55	-46	-21	-18	-30	-76	-190
0	0	0	1	0	0	0	2	3	4	5	7	8	11	14
0	0	0	0	0	0	0	-1	-2	-1	-1	-1	-1	0	0
0	0	1	1	1	-3	1	2	0	0	-9	18	-39	-14	106
0	0	0	0	1	0	2	20	40	46	46	51	79	100	100
0	0	0	1	1	1	1	0	3	1	0	0	0	0	0
0	0	0	0	0	1,000	0	0	0	0	0	0	0	0	0
-12	-14	-17	-1	0	-3	-9	-16	-14	-4	-2	33	-19	-25	-18
0	0	-1	0	0	0	-1	0	0	-7	-3	-10	-20	-24	-9
0	0	-9	0	0	-1	-1	-21	-6	-7	-22	-100	47	-228	40
0	0	-7	0	0	0	0	-20	-5	0	-19	-90	67	-204	49
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
2	1	10	1	0	0	4	16	9	-14	0	0	0	0	0
21	25	0	2	0	39	0	8	19	65	4	167	203	4	-25
23	26	10	4	0	35	4	24	29	50	0	163	185	-4	-29
-	-	-	-	-	-3.00	-	-	-	-	-4.00	-4.00	-18.00	-8.00	-3.00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
10	11	-16	3	0	31	-6	-12	9	38	-26	96	213	-258	-7
-13.14	-15.27	-19.29	-1.92	-0.65	-4.08	-10.95	-17.07	-14.5	-11.25	-6.12	23.07	-39.55	-49.57	-27.63
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

CareDx 브루토마진	CareDx 이익 마진	CareDx EBIT-마진	CareDx 이익 마진
2026e	63.61 %	6.55 %	9.52 %
2025e	63.61 %	-0.26 %	7.88 %
2024e	63.61 %	-1.72 %	6.08 %
2023	63.61 %	-37.12 %	-67.88 %
2022	65.13 %	-23.99 %	-23.8 %
2021	67.14 %	-10.02 %	-10.36 %
2020	67.17 %	-11.71 %	-9.73 %
2019	64.2 %	-19.28 %	-17.31 %
2018	56.92 %	-20.37 %	-61.1 %
2017	55.9 %	-37.89 %	-114.91 %
2016	48.03 %	-59.85 %	-97.29 %
2015	63.7 %	-42.35 %	-48.75 %
2014	68.86 %	4.76 %	2.93 %
2013	58.82 %	-4.07 %	-15.84 %
2012	60.98 %	-11.22 %	-24.88 %
2006	6.9 %	-696.55 %	-686.21 %
2005	-433.33 %	-5,433.33 %	-5,533.33 %
2004	63.61 %	0 %	0 %
2003	63.61 %	0 %	0 %
2002	63.61 %	0 %	0 %

	브루토마진	EBIT-마진	이익 마진
2002	63.61 %	0 %	0 %
2003	63.61 %	0 %	0 %
2004	63.61 %	0 %	0 %
2005	-433.33 %	-5,433.33 %	-5,533.33 %
2006	6.9 %	-696.55 %	-686.21 %
2012	60.98 %	-11.22 %	-24.88 %
2013	58.82 %	-4.07 %	-15.84 %
2014	68.86 %	4.76 %	2.93 %
2015	63.7 %	-42.35 %	-48.75 %
2016	48.03 %	-59.85 %	-97.29 %
2017	55.9 %	-37.89 %	-114.91 %
2018	56.92 %	-20.37 %	-61.1 %
2019	64.2 %	-19.28 %	-17.31 %
2020	67.17 %	-11.71 %	-9.73 %
2021	67.14 %	-10.02 %	-10.36 %
2022	65.13 %	-23.99 %	-23.8 %
2023	63.61 %	-37.12 %	-67.88 %
2024e	63.61 %	-1.72 %	6.08 %
2025e	63.61 %	-0.26 %	7.88 %
2026e	63.61 %	6.55 %	9.52 %

날짜	CareDx 주당 매출	CareDx EBIT 당 주식	CareDx 주당 이익
2026e	7.86 undefined	0 undefined	0.75 undefined
2025e	6.89 undefined	0 undefined	0.54 undefined
2024e	6.25 undefined	0 undefined	0.38 undefined
2023	5.21 undefined	-1.94 undefined	-3.54 undefined
2022	6.04 undefined	-1.45 undefined	-1.44 undefined
2021	5.68 undefined	-0.57 undefined	-0.59 undefined
2020	4.13 undefined	-0.48 undefined	-0.4 undefined
2019	3.01 undefined	-0.58 undefined	-0.52 undefined
2018	2.15 undefined	-0.44 undefined	-1.31 undefined
2017	2.07 undefined	-0.79 undefined	-2.38 undefined
2016	2.46 undefined	-1.47 undefined	-2.39 undefined
2015	2.36 undefined	-1 undefined	-1.15 undefined
2014	2.94 undefined	0.14 undefined	0.09 undefined
2013	22.1 undefined	-0.9 undefined	-3.5 undefined
2012	20.5 undefined	-2.3 undefined	-5.1 undefined
2006	0.1 undefined	-0.73 undefined	-0.72 undefined
2005	0.01 undefined	-0.59 undefined	-0.6 undefined
2004	0 undefined	-0.47 undefined	-0.47 undefined
2003	0 undefined	-0.27 undefined	-0.27 undefined
2002	0 undefined	-0.1 undefined	-0.13 undefined

	주당 매출	EBIT 당 주식	주당 이익
2002	0 USD	-0.1 USD	-0.13 USD
2003	0 USD	-0.27 USD	-0.27 USD
2004	0 USD	-0.47 USD	-0.47 USD
2005	0.01 USD	-0.59 USD	-0.6 USD
2006	0.1 USD	-0.73 USD	-0.72 USD
2012	20.5 USD	-2.3 USD	-5.1 USD
2013	22.1 USD	-0.9 USD	-3.5 USD
2014	2.94 USD	0.14 USD	0.09 USD
2015	2.36 USD	-1 USD	-1.15 USD
2016	2.46 USD	-1.47 USD	-2.39 USD
2017	2.07 USD	-0.79 USD	-2.38 USD
2018	2.15 USD	-0.44 USD	-1.31 USD
2019	3.01 USD	-0.58 USD	-0.52 USD
2020	4.13 USD	-0.48 USD	-0.4 USD
2021	5.68 USD	-0.57 USD	-0.59 USD
2022	6.04 USD	-1.45 USD	-1.44 USD
2023	5.21 USD	-1.94 USD	-3.54 USD
2024e	6.25 USD	0 USD	0.38 USD
2025e	6.89 USD	0 USD	0.54 USD
2026e	7.86 USD	0 USD	0.75 USD

Segmente	2017	2016
Patient and digital solutions	-	-
Product revenue	-	-
Testing services revenue	-	-
Digital and other revenue	-	-
Service	-	-

	Patient and digital solutions	Product revenue	Testing services revenue	Digital and other revenue	Service
2016	0 USD	0 USD	0 USD	0 USD	0 USD
2017	0 USD	0 USD	0 USD	0 USD	0 USD

Segmente	2017	2016
Digital and other	-	-
Product revenue	-	-
Testing services revenue	-	-
License and other	-	-
Product	-	-
Testing Services	-	-

	Digital and other	Product revenue	Testing services revenue	License and other	Product	Testing Services
2016	0 USD	0 USD	0 USD	0 USD	0 USD	0 USD
2017	0 USD	0 USD	0 USD	0 USD	0 USD	0 USD

Segmente	2017	2016
Digital and other revenue	-	-
Testing	-	-

	Digital and other revenue	Testing
2016	0 USD	0 USD
2017	0 USD	0 USD

Segmente	2017	2016
Royalty	-	-

	Royalty
2016	0 USD
2017	0 USD

Segmente	2017	2016
Pre transplant	14.63 백만 USD	-

	Pre transplant
2016	0 USD
2017	14.63 백만 USD

Segmente	2017	2016
Post transplant	33.69 백만 USD	-
CareDx	-	29.92 백만 USD
Olerup	-	10.71 백만 USD

	Post transplant	CareDx	Olerup
2016	0 USD	29.92 백만 USD	10.71 백만 USD
2017	33.69 백만 USD	0 USD	0 USD

날짜	Australia	Europe	Europe, Middle East and Africa	Latin America	North America	Rest of the world	Rest of World	United States
2023	-	10.17 백만 USD	-	-	-	-	4.53 백만 USD	265.63 백만 USD
2022	-	9.55 백만 USD	-	-	-	-	4.7 백만 USD	307.54 백만 USD
2021	-	9.82 백만 USD	-	-	-	-	4.57 백만 USD	282.01 백만 USD
2020	-	7.56 백만 USD	-	-	-	-	3.13 백만 USD	181.5 백만 USD
2019	-	7.79 백만 USD	-	-	-	-	3.08 백만 USD	116.2 백만 USD
2018	-	7.6 백만 USD	-	-	-	2.9 백만 USD	-	66.06 백만 USD
2017	411,000 USD	7.98 백만 USD	-	-	38.2 백만 USD	1.73 백만 USD	-	-
2016	-	-	6.99 백만 USD	424,000 USD	33.22 백만 USD	-	-	-

	Australia	Europe	Europe, Middle East and Africa	Latin America	North America	Rest of the world	Rest of World	United States
2016	0 USD	0 USD	6.99 백만 USD	424,000 USD	33.22 백만 USD	0 USD	0 USD	0 USD
2017	411,000 USD	7.98 백만 USD	0 USD	0 USD	38.2 백만 USD	1.73 백만 USD	0 USD	0 USD
2018	0 USD	7.6 백만 USD	0 USD	0 USD	0 USD	2.9 백만 USD	0 USD	66.06 백만 USD
2019	0 USD	7.79 백만 USD	0 USD	0 USD	0 USD	0 USD	3.08 백만 USD	116.2 백만 USD
2020	0 USD	7.56 백만 USD	0 USD	0 USD	0 USD	0 USD	3.13 백만 USD	181.5 백만 USD
2021	0 USD	9.82 백만 USD	0 USD	0 USD	0 USD	0 USD	4.57 백만 USD	282.01 백만 USD
2022	0 USD	9.55 백만 USD	0 USD	0 USD	0 USD	0 USD	4.7 백만 USD	307.54 백만 USD
2023	0 USD	10.17 백만 USD	0 USD	0 USD	0 USD	0 USD	4.53 백만 USD	265.63 백만 USD

	주식 수량
2002	27.8 백만 Aktien
2003	27.8 백만 Aktien
2004	27.8 백만 Aktien
2005	27.8 백만 Aktien
2006	27.8 백만 Aktien
2012	1 백만 Aktien
2013	1 백만 Aktien
2014	9.3 백만 Aktien
2015	11.9 백만 Aktien
2016	16.5 백만 Aktien
2017	23.3 백만 Aktien
2018	35.6 백만 Aktien
2019	42.2 백만 Aktien
2020	46.5 백만 Aktien
2021	52.2 백만 Aktien
2022	53.3 백만 Aktien
2023	53.76 백만 Aktien
2024e	53.76 백만 Aktien
2025e	53.76 백만 Aktien
2026e	53.76 백만 Aktien

EPS-예상치	EPS-실제	보고 분기
0.01	0.14 (1,272.55 %)	2024 Q3
-0.15	0.25 (270.18 %)	2024 Q2
-0.21	-0.03 (85.72 %)	2024 Q1
-0.27	-0.17 (37.43 %)	2023 Q4
-0.4	-0.18 (55.37 %)	2023 Q3
-0.32	-0.18 (43.07 %)	2023 Q2
-0.11	-0.11 (0.18 %)	2023 Q1
-0.09	-0.07 (20.36 %)	2022 Q4
-0.14	-0.06 (57.98 %)	2022 Q3
-0.11	-0.13 (-13.84 %)	2022 Q2
-0.05	-0.13 (-154.9 %)	2022 Q1
0.03	-0.03 (-190.36 %)	2021 Q4
0.01	0.07 (473.77 %)	2021 Q3
0.05	0.11 (107.55 %)	2021 Q2
0.01	0.14 (2,645.1 %)	2021 Q1
0.02	0.08 (265.3 %)	2020 Q4
-0.04	0.1 (330.41 %)	2020 Q3
-0.04	0.04 (198.04 %)	2020 Q2
0.03	0 (-100 %)	2020 Q1
0.02	0.04 (161.44 %)	2019 Q4
0.01	0.02 (96.08 %)	2019 Q3
0	0 (-100 %)	2019 Q2
-0.03	0.05 (250.6 %)	2019 Q1
-0	0.01 (484.62 %)	2018 Q4
-0.03	-0.01 (70.59 %)	2018 Q3
-0.07	-0.04 (43.98 %)	2018 Q2
-0.13	-0.14 (-5.58 %)	2018 Q1
-0.13	-0.09 (32.13 %)	2017 Q4
-0.17	-0.15 (13.49 %)	2017 Q3
-0.2	-0.17 (13.79 %)	2017 Q2
-0.22	-0.32 (-42.6 %)	2017 Q1
-0.18	-0.13 (27.17 %)	2016 Q4
-0.25	-0.15 (39.98 %)	2016 Q3
-0.28	-0.29 (-3.39 %)	2016 Q2
-0.31	-0.37 (-17.76 %)	2016 Q1
-0.35	-0.37 (-6.08 %)	2015 Q4
-0.26	-0.32 (-24.51 %)	2015 Q3
-0.19	-0.26 (-39.63 %)	2015 Q2
-0.18	-0.21 (-17.65 %)	2015 Q1
-0.11	0 (100 %)	2014 Q4
-0.14	-0.01 (92.6 %)	2014 Q3
-0.13	-0.09 (32.13 %)	2014 Q2

%-지분	이름	주식	변경
10.63276 %	ARK Investment Management LLC	5,702,351	-161,695
8.16918 %	The Vanguard Group, Inc.	4,381,132	81,116
8.02517 %	BlackRock Institutional Trust Company, N.A.	4,303,896	-72,594
7.29550 %	Bellevue Asset Management AG	3,912,575	-21,431
4.80377 %	Nikko Asset Management Co., Ltd.	2,576,261	-172,077
3.99200 %	Millennium Management LLC	2,140,909	1,960,308
3.79655 %	State Street Global Advisors (US)	2,036,089	-71,741
3.49930 %	Baron Capital Management, Inc.	1,876,672	646,772
3.44439 %	Gagnon Securities LLC	1,847,226	-326,941
3.22187 %	D. E. Shaw & Co., L.P.	1,727,890	-294,244
2.82062 %	Renaissance Technologies LLC	1,512,700	88,100
2.39402 %	Dimensional Fund Advisors, L.P.	1,283,912	-161,890
2.22932 %	Geode Capital Management, L.L.C.	1,195,583	527
2.19661 %	Jacobs Levy Equity Management, Inc.	1,178,040	27,068
2.14358 %	Fred Alger Management, LLC	1,149,602	963,554
1.80599 %	First Eagle Investment Management, L.L.C.	968,552	-36,555
1.27081 %	BlackRock Financial Management, Inc.	681,538	-46,926
1.13753 %	Acadian Asset Management LLC	610,055	-259,463
1.06666 %	BMO Capital Markets (US)	572,050	-6
0.95096 %	Blue Water Life Science Advisors, LP.	510,000	510,000
0.90957 %	Hanna (John Walter JR)	487,804	487,804
0.90608 %	Charles Schwab Investment Management, Inc.	485,933	-82,567
0.87144 %	Morgan Stanley & Co. LLC	467,355	-290,684
0.80332 %	Gagnon Advisors, LLC	430,819	-179,517
0.73147 %	Royce Investment Partners	392,286	-146,012
0.72846 %	Connor, Clark & Lunn Investment Management Ltd.	390,671	128,926
0.71821 %	Northern Trust Investments, Inc.	385,174	-17,499
0.69924 %	Medical Strategy GmbH	375,000	0
0.69761 %	Goldman Sachs & Company, Inc.	374,130	-61,884
0.57180 %	Victory Capital Management Inc.	306,654	104,505
0.56482 %	Maag (Peter)	302,912	-8,844
0.50631 %	Gagnon (Neil)	271,533	-28,608
0.46724 %	BofA Global Research (US)	250,581	82,108
0.46690 %	Oberweis Asset Management, Inc.	250,400	250,400
0.46202 %	Two Sigma Investments, LP	247,780	-28,734
0.42551 %	Calamos Advisors LLC	228,202	136,361
0.38222 %	Allspring Global Investments, LLC	204,987	183,823
0.37724 %	Wellington Management Company, LLP	202,312	13,602
0.35606 %	Columbia Threadneedle Investments (US)	190,953	2,955
0.35428 %	Intrinsic Edge Capital Management, LLC	190,000	190,000
0.34793 %	Conestoga Capital Advisors, LLC	186,593	0
0.34462 %	Bullseye Asset Management LLC	184,820	10,000
0.34237 %	Driehaus Capital Management, LLC	183,613	183,613
0.34079 %	Engineers Gate Manager, L.P.	182,765	-6,829
0.33574 %	AQR Capital Management, LLC	180,059	-269,082
0.29899 %	Susquehanna International Group, LLP	160,350	125,081
0.29757 %	Parametric Portfolio Associates LLC	159,586	-11,314
0.28654 %	Jane Street Capital, L.L.C.	153,670	153,670
0.28454 %	BlackRock Investment Management, LLC	152,600	1,814
0.26658 %	DWS Investments UK Limited	142,967	-3,949
0.25365 %	Nuveen LLC	136,031	0
0.25076 %	Seeto (Reginald)	134,482	128,583
0.23452 %	BNY Mellon Asset Management	125,772	3,365
0.23181 %	Cohen (Frederick E)	124,318	10,570
0.22950 %	Mirae Asset Global Investments (USA) LLC	123,082	-105,116
0.22748 %	Voloridge Investment Management, LLC	121,996	121,996
0.22469 %	Citadel Advisors LLC	120,501	40,440
0.21893 %	BlackRock Advisors (UK) Limited	117,413	7,985
0.21139 %	UBS Financial Services, Inc.	113,370	-112,796
0.20969 %	PGIM Quantitative Solutions LLC	112,459	2,200
0.20872 %	Los Angeles Capital Management LLC	111,936	-147,071
0.20206 %	American Century Investment Management, Inc.	108,366	11,168
0.19031 %	Goldberg (Michael D)	102,063	837
0.18031 %	Bickerstaff (George W III)	96,702	10,570
0.17879 %	ARS Investment Partners LLC	95,885	14,450
0.16676 %	Rafferty Asset Management LLC	89,434	-275,365
0.16661 %	Ohio Public Employees Retirement System	89,351	-5,407
0.16347 %	State of Wisconsin Investment Board	87,667	-97,846
0.15700 %	Goldman Sachs Asset Management, L.P.	84,200	-10,052
0.15693 %	Rhumbline Advisers Ltd. Partnership	84,159	-3,646
0.15165 %	Thrivent Asset Management, LLC	81,331	-3,473
0.14094 %	Jackson Creek Investment Advisors LLC	75,584	-45,413
0.14052 %	Invesco Capital Management LLC	75,360	852
0.13502 %	BlackRock Asset Management Ireland Limited	72,413	-20,139
0.13079 %	Legal & General Investment Management Ltd.	70,142	-19,115
0.13071 %	Kennedy (Keith S)	70,101	70,101
0.12926 %	Fidelity Management & Research Company LLC	69,320	4,815
0.12721 %	Mellon Investments Corporation	68,222	9,039
0.12689 %	AllianceBernstein L.P.	68,050	0
0.12267 %	Assenagon Asset Management S.A.	65,787	-100,518
0.12176 %	HRT Financial LP	65,299	65,299
0.11939 %	ClariVest Asset Management LLC	64,027	1,810
0.11586 %	Russell Investments Trust Company	62,136	22,019
0.10847 %	Avantis Investors	58,173	14,842
0.10388 %	Marshall Wace LLP	55,711	-211,002
0.10289 %	Cetera Advisor Networks LLC	55,179	2,128
0.10282 %	Virtus Investment Advisers, Inc.	55,145	17,000
0.09803 %	Meng (Jessica)	52,576	52,576
0.09387 %	LSV Asset Management	50,342	0
0.09372 %	Jacob Asset Management of New York, LLC	50,260	25,795
0.09029 %	Balyasny Asset Management LP	48,423	48,423
0.08824 %	Ronai (Abraham)	47,324	-315,554
0.08662 %	Y-Intercept (Hong Kong) Ltd	46,453	46,453
0.08550 %	Dimensional Fund Advisors, Ltd.	45,852	0
0.08392 %	Main Management ETF Advisors, LLC	45,008	58
0.08159 %	Barclays Bank PLC	43,756	-15,098
0.08131 %	BlackRock Fund Advisors	43,608	43,608
0.07797 %	Guggenheim Investments	41,817	-13,890
0.07717 %	Raymond James Financial Services Advisors, Inc.	41,388	-7,800
0.07561 %	Curi RMB Capital, LLC	40,547	0

What values and corporate philosophy does CareDx represent?

CareDx Inc represents values of innovation, patient-centricity, and excellence in personalized medicine. The company is committed to transforming patient care through transplant diagnostics and novel digital health solutions. CareDx emphasizes collaboration with clinicians and industry partners to deliver breakthrough technologies that improve outcomes for transplant patients. With a focus on providing accurate, timely, and actionable information, CareDx strives to empower healthcare professionals with the tools needed to make informed decisions and improve patient lives. By leveraging their expertise in genomics and diagnostic testing, CareDx is driving advancements in the field of transplantation and leading the way in improving the standard of care.

In which countries and regions is CareDx primarily present?

CareDx Inc is primarily present in the United States, with its headquarters located in Brisbane, California. As a leading precision medicine company, CareDx focuses on improving patient outcomes through advancing diagnostic solutions for transplant patients. With a wide range of innovative products and services, CareDx aims to optimize transplant management and enhance long-term patient care. While CareDx operates globally, its primary presence remains concentrated within the United States.

What significant milestones has the company CareDx achieved?

CareDx Inc has achieved several significant milestones since its inception. The company has made notable advancements in the field of transplant diagnostics. It has successfully developed and commercialized innovative testing solutions, such as AlloSure and AlloMap, which help healthcare professionals monitor organ transplant recipient's immune system. CareDx Inc has also expanded its portfolio with the acquisition of other diagnostic technologies, allowing it to offer a comprehensive range of solutions. Additionally, the company has collaborated with renowned transplant centers and research institutions, further enhancing its expertise and reputation in the field. These accomplishments demonstrate CareDx Inc's commitment to improving transplant patient outcomes through cutting-edge diagnostics.

What is the history and background of the company CareDx?

CareDx Inc is a leading precision medicine company focused on transforming patient care through diagnostic solutions. Established in 1998, CareDx specializes in transplant diagnostics, offering a comprehensive suite of products and services to assess the health of transplanted organs. The company's innovative technologies, such as AlloSure and AlloMap, enable healthcare providers to monitor transplant patients and personalize treatment plans. With a strong commitment to improving outcomes for transplant recipients, CareDx has played a significant role in advancing transplant medicine. CareDx Inc continues to be a trusted name in the healthcare industry, providing valuable insights and solutions for clinicians and patients alike.

Who are the main competitors of CareDx in the market?

The main competitors of CareDx Inc in the market include companies such as Natera Inc, Illumina Inc, and Thermo Fisher Scientific Inc.

In which industries is CareDx primarily active?

CareDx Inc is primarily active in the biotechnology and healthcare industries.

What is the business model of CareDx?

The business model of CareDx Inc. revolves around providing personalized medicine solutions for transplant patients. CareDx utilizes advanced diagnostic tools and technology to improve the outcome of organ transplant procedures. The company specializes in developing and delivering innovative molecular diagnostic solutions, including its flagship product, AlloSure, which helps assess the health and function of transplanted organs. CareDx Inc. also offers a comprehensive portfolio of transplant surveillance products and services to aid physicians in managing patients post-transplant. With a focus on organ transplant patients, CareDx aims to enhance patient care and optimize transplant outcomes through its cutting-edge molecular diagnostic solutions.

CareDx 2024의 P/E 비율은 얼마입니까?

CareDx의 P/E 비율은 57.56입니다.

CareDx 2024의 KUV는 얼마입니까?

CareDx의 P/S 비율은 3.5입니다.

CareDx의 AlleAktien 품질 점수는 얼마인가요?

CareDx에 대한 AlleAktien 품질 점수는 6/10입니다.

CareDx 2024의 매출은 얼마인가요?

예상되는 CareDx 매출은 335.28 백만 USD입니다.

CareDx 2024의 이익은 얼마인가요?

예상되는 CareDx 이익은 20.4 백만 USD입니다.

CareDx은 무엇을 하나요?

CareDx Inc. is a leading company in the field of diagnostic medicine and offers a wide range of products and services for transplant patients. The company is headquartered in Brisbane, California and specializes in the development, manufacturing, and marketing of solutions for monitoring and treating transplant patients. CareDx Inc. is divided into various divisions, each offering different products and services. Here are some of the main divisions of the company: Transplant Diagnostics: This division of CareDx Inc. offers a variety of tests for monitoring transplant patients. These include diagnostic tests for identifying donor and recipient characteristics, blood tests for monitoring immunosuppression, and molecular tests for determining rejection rates. These tests help doctors monitor the status of the transplant and treat it specifically. Transplant Patient Monitoring: This division of CareDx Inc. offers monitoring systems for transplant patients. These systems allow doctors to continuously monitor the patient's condition and detect early signs of rejection or other complications. The systems include devices for measuring weight, blood pressure, pulse, and other vital parameters. Transplant Care: This division of CareDx Inc. offers a wide range of services for transplant patients. These include personal care, patient and caregiver education, and support for accessing treatment services. The goal of these services is to provide comprehensive support to patients and help them achieve optimal outcomes after transplantation. Transplant Business: This division of CareDx Inc. offers specialized products and services for transplant centers and hospitals. These include training for medical staff, consulting services for best practices in transplant medicine, and specialized software for monitoring transplant patients. CareDx Inc. offers a wide range of products and services for transplant patients, all aimed at improving patient outcomes and quality of life. The company has a strong research and development department that continuously strives to develop innovative products and technologies to improve transplant medicine. The company works closely with transplant centers and medical professionals to ensure that patients' needs are met and that they receive optimal care. SEO Optimization: CareDx Inc. is a leading company in the field of diagnostic medicine and offers a wide range of products and services for transplant patients. The company is divided into various divisions, each offering different products and services. CareDx Inc. has a strong research and development department that continuously strives to develop innovative products and technologies. The company works closely with transplant centers and medical professionals to ensure that patients' needs are met. If you are looking for high-quality products and services for transplant patients, then CareDx Inc. is your best choice.

CareDx 배당금은 얼마입니까?

CareDx은(는) 연간 번의 배당을 통해 0 USD의 배당금을 지급합니다.

CareDx이 얼마나 자주 배당을 지급하나요?

CareDx의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

CareDx ISIN이 무엇입니까?

CareDx의 ISIN은 US14167L1035입니다.

CareDx WKN은 무엇인가요?

CareDx의 WKN은 A118WG입니다.

CareDx 티커는 무엇인가요?

CareDx의 티커는 CDNA입니다.

CareDx이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 CareDx은(는) 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 CareDx은(는) 0 USD의 배당금을 지급할 것으로 예상됩니다.

CareDx의 배당 수익률은 얼마입니까?

CareDx의 현재 배당 수익률은 입니다.

CareDx의 배당금은 언제 지급되나요?

CareDx은 분기별로 배당금을 지급합니다. 이는 월에 배당됩니다.

CareDx의 배당금은 얼마나 안전한가요?

CareDx은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

CareDx의 배당금은 얼마입니까?

향후 12개월 동안 0 USD의 배당금이 예상됩니다. 이는 배당수익률 0 %에 해당합니다.

CareDx이(가) 속해 있는 섹터는 어디인가요?

CareDx은 '건강' 섹터에 속합니다.

Wann musste ich die Aktien von CareDx kaufen, um die vorherige Dividende zu erhalten?

CareDx의 마지막 배당금을 0 USD만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

CareDx의 마지막 배당금 지급일은 언제였습니까?

마지막 배당금 지급일은 입니다.

CareDx의 2023년도 배당금은 얼마였습니까?

2023년에 CareDx는 0 USD를 배당금으로 지급했습니다.

CareDx는 어떤 화폐로 배당금을 지급하나요?

CareDx의 배당금은 USD에 지급됩니다.

Scope 1 - 직접 방출	1,080.02
스코프 2 - 구매한 에너지로부터의 간접적인 배출
Scope 3 - 가치 창출 체인 내의 간접 배출
총 CO₂ 배출량	1,080.02
CO₂ 감소 전략
석탄 에너지
원자력
동물 실험
펠츠 & 레더
살충제
팜 오일
담배
유전자 변형 생물체
기후 개념
지속 가능한 임업
재활용 규정
환경 친화적인 포장
위험물질
연료 소비량과 효율성
물 사용량 및 효율성

여성 직원 비율	57.8
관리 직위에서의 여성 비율
아시아 직원 비율
아시아 경영진 비율
히스패닉/라티노 직원 비율
히스패닉/라티노 관리 부문 지분
흑인 직원 비율
블랙 매니지먼트 지분
흰색 종업원의 비율
화이트 매니지먼트 지분
성인 콘텐츠
알코올
무기
총기
도박
군사 계약
인권 개념
개인정보 보호 정책
작업 및 건강 보호
카톨릭

환경 보고
이해관계자 참여
콜백 정책
카르텔법

증권거래소	CareDx 티커
뒤셀도르프	1K9.DU
프랑크푸르트	1K9
뮌헨	1K9.MU
NASDAQ	CDNA
NEW YORK

CareDx 티커	CareDx FIGI
CDNA:US	BBG006JS5785
CDNA:UA	BBG006LCXWT8
CDNA:UC	BBG006LCXWV5
CDNA:UN	BBG006LCXWX3
CDNA:UP	BBG006LCXWY2
CDNA:UQ	BBG006LCXWZ1
CDNA:UB	BBG006LCXX07
CDNA:UM	BBG006LCXX25
CDNA:UX	BBG006LCXX34
CDNA:UD	BBG006LCXX98
CDNA:UF	BBG006LCXXD3
CDNA:VY	BBG006LCXXF1
CDNA:VJ	BBG006LCXXG0
CDNA:VK	BBG006LCXXH9
CDNA:VF	BBG00DJGZHX3
1K9:GR	BBG00HBHJPN1
1K9:GF	BBG00HBHJPP9
1K9:GD	BBG00HBHJPQ8
1K9:GS	BBG00HBHJPS6
1K9:GM	BBG00HBHJPT5
1K9:GB	BBG00HBHJPV2
CDNAEUR:EO	BBG00HBQ97T6
CDNAEUR:XH	BBG00HBQ97X1
CDNAEUR:XF	BBG00HBQ97Z9
CDNAEUR:XE	BBG00HBQ9814
CDNAEUR:XJ	BBG00HBQ9823
CDNAEUR:XL	BBG00HBQ9832
CDNAEUR:XG	BBG00HBQ9841
CDNAEUR:XO	BBG00HBQ9850
CDNAEUR:XS	BBG00HBQ9896
CDNAEUR:XA	BBG00HBQ98B3
CDNAEUR:E1	BBG00HBQ98C2
CDNAEUR:XT	BBG00HBQ98D1
CDNAEUR:XW	BBG00HBQ98F9
CDNAEUR:XU	BBG00HBQ98G8
CDNAEUR:XV	BBG00HBQ98H7
CDNAEUR:EU	BBG00HBQ98K3
CDNAEUR:XX	BBG00JN8N2V1
CDNAGBP:XS	BBG00KTFNFL8
CDNAGBP:XH	BBG00KTFNFP4
CDNAGBP:XF	BBG00KTFNFR2
CDNAGBP:XE	BBG00KTFNFT0
CDNAGBP:XJ	BBG00KTFNFV7
CDNAGBP:XL	BBG00KTFNFW6
CDNAGBP:XG	BBG00KTFNFX5
CDNAGBP:XO	BBG00KTFNFY4
CDNAGBP:XA	BBG00KTFNG27
CDNAGBP:E1	BBG00KTFNG36
CDNAGBP:XT	BBG00KTFNG45
CDNAGBP:XW	BBG00KTFNG54
CDNAGBP:XU	BBG00KTFNG63
CDNAGBP:XV	BBG00KTFNG72
CDNAGBP:XM	BBG00KTFNG81
CDNAGBP:XQ	BBG00KTFNGB7
CDNAGBP:XX	BBG00KTFNGC6
CDNAGBP:XZ	BBG00KTFNGD5
CDNAGBP:EU	BBG00KTFNGG2
1K9:GZ	BBG00MM7C490
1K9:TH	BBG00MM7ZKQ0
1K9:QT	BBG00MNSJ7L5
CDNA:VG	BBG00X1P87K4
CDNA:VP	BBG00X1SPMX2
CDNAUSD:EP	BBG00XRH9KN1
CDNAUSD:EZ	BBG00XRH9KT5
CDNAUSD:XS	BBG00XRH9L86
CDNAUSD:X2	BBG00XRH9L95
CDNAUSD:XH	BBG00XRH9LC1
CDNAUSD:XF	BBG00XRH9LF8
CDNAUSD:XE	BBG00XRH9LH6
CDNAUSD:XJ	BBG00XRH9LJ4
CDNAUSD:XL	BBG00XRH9LK2
CDNAUSD:XG	BBG00XRH9LM0
CDNAUSD:XO	BBG00XRH9LN9
CDNAUSD:XA	BBG00XRH9LV0
CDNAUSD:E1	BBG00XRH9LX8
CDNAUSD:XT	BBG00XRH9LZ6
CDNAUSD:XW	BBG00XRH9M02
CDNAUSD:XU	BBG00XRH9M20
CDNAUSD:XV	BBG00XRH9M57
CDNAUSD:XM	BBG00XRH9M66
CDNAUSD:XQ	BBG00XRH9M84
CDNAUSD:XX	BBG00XRH9M93
CDNAUSD:XZ	BBG00XRH9MC9
CDNAUSD:X1	BBG00XRH9MH4
CDNAUSD:EU	BBG00XRH9NM6
1K9:LA	BBG018H9JCP9
1K9:LU	BBG018J35DF4

한 눈에 저평가된 주식을 인식하세요

CareDx 주식 주식과 주식 분석 CareDx ariva, CareDx onvista, CareDx finanzen.net, CareDx aktienfinder, CareDx marketscreener, CareDx marketwatch, CareDx bloomberg, CareDx handelsblatt, CareDx wiwo, CareDx forum

가격

가격

티커CDNA

ISINUS14167L1035

WKNA118WG

CareDx 주식 가격

가격

개요

인트라데이 기능

총 수익률 및 상대 가격 변동

해석 및 투자

CareDx 주가 이력

CareDx 주식 매출, EBIT, 이익 US14167L1035 · A118WG

매출, 이익 & EBIT

매출, EBIT, 소득 이해하기

연간 분석 및 비교

투자 기대치 활용

투자 통찰력

CareDx 매출, 이익 및 EBIT 역사

CareDx 주식 지표

손익계산서

매출 성장

총 이익률

EBIT와 EBIT 마진

수입과 성장

발행 주식

연간 비교의 해석

기대치와 예측

재무 상태표

재무 상태표 이해

자산

부채

자본

년대비 분석

데이터 해석

CareDx 주식 마진 US14167L1035 · A118WG

마진

매출 총이익률 이해

EBIT 마진 분석

매출 마진에 대한 인사이트

기대치 해석

비교 분석

CareDx 마진 역사

CareDx 주식 매출, EBIT, 주당 순이익 US14167L1035 · A118WG

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

CareDx 매출, 이익 및 EBIT 주당 역사

CareDx 주식 및 주식 분석

CareDx 매출 세분화 US14167L1035 · A118WG

세그먼트별 매출

세그먼트별 매출 개요

해석 및 사용

투자 전략

CareDx 매출 세분화

세그먼트별 매출

세그먼트별 매출 개요

해석 및 사용

투자 전략

CareDx 매출 세분화

세그먼트별 매출

세그먼트별 매출 개요

해석 및 사용

투자 전략

CareDx 매출 세분화

세그먼트별 매출

세그먼트별 매출 개요

해석 및 사용

투자 전략

CareDx 매출 세분화

세그먼트별 매출

세그먼트별 매출 개요

해석 및 사용

투자 전략

CareDx 매출 세분화

세그먼트별 매출

CareDx 주식
주식과 주식 분석 CareDx ariva, CareDx onvista, CareDx finanzen.net, CareDx aktienfinder, CareDx marketscreener, CareDx marketwatch, CareDx bloomberg, CareDx handelsblatt, CareDx wiwo, CareDx forum

티커
CDNA

ISIN
US14167L1035

WKN
A118WG